Location History:
- Somerville, MA (US) (2019)
- Cambridge, MA (US) (2022 - 2023)
Company Filing History:
3 out of 443 
3 out of 8,373 
1 out of 1,209 
Years Active: 2019-2023
Title: Liyi Xu: Innovator in Cellular Transformation and Nucleic Acid Quantification
Introduction
Liyi Xu is a prominent inventor based in Somerville, MA (US), known for his significant contributions to the fields of cellular transformation and nucleic acid quantification. With a total of 3 patents, Xu has developed innovative methods that have the potential to advance medical research and therapeutic applications.
Latest Patents
One of Liyi Xu's latest patents is titled "High-throughput drug and genetic assays for cellular transformation." This invention discloses a method for detecting oncogenic growth and viability, as well as identifying agents that inhibit cellular transformation. The method involves providing a cellular sample, culturing it under low attachment conditions, and detecting growth or cell viability. Increased growth or viability relative to a control indicates cellular transformation. Additionally, the method may include introducing an expression vector into the cells to test for transformation ability. Another notable patent focuses on "Methods for quantitating DNA using digital multiple displacement amplification." This invention relates to quantifying and amplifying nucleic acid molecules by partitioning a reaction sample into droplets or a gel, allowing for effective nucleic acid amplification.
Career Highlights
Liyi Xu has worked with esteemed organizations such as the Broad Institute, Inc. and the Massachusetts Institute of Technology. His work in these institutions has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in his field.
Collaborations
Throughout his career, Liyi Xu has collaborated with notable colleagues, including Paul Blainey and Asaf Rotem. These partnerships have further enriched his research and innovation efforts.
Conclusion
Liyi Xu's innovative work in cellular transformation and nucleic acid quantification showcases his dedication to advancing scientific knowledge and medical applications. His patents reflect a commitment to improving methodologies that can have a lasting impact on research and healthcare.